Vasculitis Screen and Autoimmune Screen - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Vasculitis Screen and Autoimmune Screen

Description:

Vasculitis Screen and Autoimmune Screen Theo de Malmanche * * * * * * * * * * * * * * * * * * Levels of confidence Biopsy with typical findings Biopsy ... – PowerPoint PPT presentation

Number of Views:153
Avg rating:3.0/5.0
Slides: 42
Provided by: gardinerl
Category:

less

Transcript and Presenter's Notes

Title: Vasculitis Screen and Autoimmune Screen


1
Vasculitis ScreenandAutoimmune Screen
  • Theo de Malmanche

2
Put this in your search engine
  • RCPAmanual

3
(No Transcript)
4
Your lab
  • Can put HAPS in your search engine

5
Or ring 14000 and ask for a chat with someone who
knows about (whatever it is)..
6
The brief
7
  • TERM 2 PATHOLOGY TESTS ORDERING AND
    INTERPRETATION
  • Should ideally include, but not be limited to, a
    discussion of the following points
  • 1. Local systems for test ordering
  • 2. Rational test ordering, with consideration of
  • a. Costs
  • b. Clinical benefit to the patient
  • 3. Common order sets - what they include and
    their interpretation
  • a. Vasculitic/autoimmune screen
  • b. Coagulopathic screen
  • c. Haemolysis screen
  • d. Hepatitis screen
  • e. Atypical pneumonia serology
  • 4. Basic interpretation of common tests when to
    be concerned
  • a. Full blood count
  • b. Electrolytes (EUC and CMP)
  • c. Coagulation profile
  • d. Liver function tests

8
1. Local systems for test ordering
  • Prof Kellerman also discussing this

9
Who really cares about the forms?
  • Request forms are a form of consultation
  • Consequence of incomplete or inaccurate request
    forms are traceable
  • These forms are required by law to be retained
  • When reviewing results, I am often guided by the
    level of detail.
  • If you do not care about the patients result,
    then you must have a low pre-test probability

10
Who reads the forms?
  • At least
  • The blood collector
  • Specimen reception staff
  • Data entry staff
  • Lab scientific staff to confirm test selection
  • Lab scientific staff interpretation of result
  • Pathologist when validating results

11
  • 2. Rational test ordering, with consideration of
  • a. Costs
  • b. Clinical benefit to the patient

12
Example of cost to taxpayer of testing
  • (values are 85 MBS, i.e done in public hospital
    lab, on inpatients)

13
(No Transcript)
14
Competing pressures
  • Cost of bedstay in NSW hospitals 500 per day
  • A delayed diagnosis can be expensive
  • Directly and indirectly
  • Every request form is a new venepuncture
  • Can it be added on?
  • Can it wait until Monday or Tuesday?
  • Unnecessary testing leads to more testing.
  • This may delay discharge

15
  • 3. Common order sets - what they include and
    their interpretation
  • a. Vasculitic/autoimmune screen
  • b. Coagulopathic screen
  • c. Haemolysis screen
  • d. Hepatitis screen
  • e. Atypical pneumonia serology
  • Haematology talk in next term

16
Vasculitis ScreenandAutoimmune Screen
  • 15 min on the tests you should not order
  • Theo de Malmanche

17
(No Transcript)
18
(No Transcript)
19
  • First - the symptoms
  • Second signs
  • Third the provisional diagnosis
  • Then Fourth the test

20
For immune disorders
  • Systems review eg. head to toe
  • What are the symptoms
  • Are there features suggesting inflammation
    without infection?
  • Is it inflammatory?
  • Is it organ threatening?
  • Do we need to biopsy?
  • Then, which tests might support the provisional
    diagnosis?
  • What can we use as a marker of inflammation?
  • Number of joints, extent of rash, duration of
    stiffness, frequency or duration of episodes

21
If in doubt Hold Serum
  • A low level / borderline / indeterminate result
    of questionable significance will cause more
    trouble than it is worth
  • eg. B27 pos now what? ?XR Lspine?
  • Serological tests can be added on at a later date
    to stored serum
  • Tests like B27, DQ2/DQ8, HFE testing are the same
    throughout life, no urgency

22
(No Transcript)
23
(No Transcript)
24
Vasculitis what it is (clinically)
  • Features include
  • Features of inflammation
  • Features of ischaemia
  • Associated specific features

25
Vasculitis what it is (clinically)
  • Often some features of inflammation without
    distinct focus
  • Eg. Fatigue, myalgia, sweats, weight loss
  • May be reflected in inflammatory markers eg. CRP
  • Tissue ischaemia
  • Which may or may not lead to organ dysfunction

26
Symptoms vary with organ(s) affected
27
Redundancy
  • Picking off blood supply to some organs will
    only have noticeable effect on function when the
    functioning mass is sufficiently reduced
  • Kidney, lung
  • Other organs will be symptomatic as soon as blood
    flow is reduced
  • Brain

28
Collaterals - chronicity
  • Collaterals develop if the reduction of blood
    flow has been a gradual process
  • Tissue ischaemia leads to growth factor release
  • This leads to new blood vessel formation

29
Symptom complexes - ischaemia
  • Skin involvement
  • Rash, especially pupurae
  • Cerebral involvement
  • CNS dysfunction, can be like a stroke
  • Renal involvement
  • Renal failure, an active sediment
  • Renal failure -gt hypertension
  • Mesenteric involvement
  • Pain after eating, bleeding into bowel, gut
    infarction, scrotal pain
  • Muscle involvement
  • Muscle pain and tenderness, cramping
  • Scalp -gt headaches
  • Tongue and mastoid mm. cramping classic in GCA
  • Retinal involvement
  • Visual loss, usually permanent
  • Heart involvement
  • Acute coronary syndrome (occlusion) or angina
    (stenoses)
  • Peripheral nerve involvement
  • Peripheral neuropathy, can be mononeuritis or
    symmetrical

30
Specific features
  • These are often hard to find
  • Detectable vasculitis
  • Tenderness and swelling of the vessels
  • Esp temporal arteries in GCA, but also carotids
    and subclavians
  • Bruits but more due to something other than
    vasculitis
  • Eg axillary in GCA
  • Granulomatous features in granulomatous
    vasculitis
  • Eg. Granulomatous sinusitis, lung granulomata
  • Asthma in Churg-Strauss Syndrome
  • Precedent pharyngitis in Henoch-Schonlein
    Purpurae

31
Vasculitis what it is not
  • Thrombosis without inflammation
  • Thromboembolic, cholesterol, plaque rupture
  • Vasculopathy without inflammation
  • Atherosclerosis, fibromuscular dysplasia,
    congophilic angiopathy, cystic medial dysplasia,
  • The above are more common than vasculitis
  • Also
  • Vasospasm
  • Organ dysfunction without vasculitis
  • Cerebritis
  • These do not improve with immunosuppression

32
Suggested approach
  • Which organs are involved
  • Systems review (history)
  • General examination
  • Urinanalysis
  • Severity
  • Are any organs threatened?
  • Evidence of inflammation?
  • Consider confirmation of diagnosis
  • If organ threatening treat with steroids, chase
    diagnosis
  • If not organ threatening chase diagnosis

33
Diagnosis of vasculitis
  • Gold standard
  • Biopsy showing necrotising vasculitis
  • Inflammation with disruption of vascular
    structures
  • Surrogates
  • Imaging demonstrating vascular damage
  • Evidence of this being inflammatory
  • Classic syndrome typical of known vasculitis
  • Exclusion of other likely causes

34
Levels of confidence
  • Biopsy with typical findings
  • Biopsy with consistent findings
  • Conventional angiogram with classic findings
  • CT angiogram with classic findings
  • Magnetic resonance angiography
  • Nuclear scans
  • Clinical syndrome

35
Standard of proof
  • Is your diagnosis
  • Beyond reasonable doubt?
  • On the balance of probabilities?
  • On reasonable suspicion?
  • On justifiable grounds?
  • When the patient has an adverse effect, how
    justified was your decision to treat?
  • Consider severity (urgency) and confidence of
    diagnosis

36
Treatment approach
  • Halt progression / Induce remission
  • Steroids
  • Consolidate remission
  • Steroids and ?cyclophosphamide
  • Maintainence (prevent relapse)
  • Steroid sparers eg. Methotrexate, azathioprine

37
Natural history
  • Bad (will lead to organ failure /- death)
  • ANCA-associated vasculitides
  • Granulomatous vasculitis (nee WG), Churg Strauss
    Syndrome, microscopic polyangiitis
  • Polyarteritis Nodosa, Temporal arteritis
  • Meningococcaemia
  • Dengue Haemorrhagic fever
  • Not so bad
  • Leucocytoclastic vasculitis
  • Eg due to medication, viral infection, Sjogrens
    Syndrome
  • Henoch-Schonlein Purpurae
  • Rarely needs therapy

38
The vasculitis screen
  • Look for evidence of ischaemia
  • Systems review
  • Look for evidence of inflammation
  • Examination, including UA
  • Consider biopsy
  • One sample needs to be not fixed (not formalin)
  • Consider supportive evidence

39
(No Transcript)
40
Which have helpful blood tests?
  • No
  • ANCA
  • ANCA
  • No
  • No
  • No
  • No
  • No

41
  • If in doubt, hold serum, or ask someone
  • Rubbish in, rubbish out
Write a Comment
User Comments (0)
About PowerShow.com